Important Safety Information
MACUGEN® (pegaptanib sodium injection) is approved to treat wet age-related macular degeneration. It is available by prescription only.
Not all people respond the same to MACUGEN, so individual results may vary. The safety or efficacy of MACUGEN has not been proven beyond 2 years.
Important Safety Information
With MACUGEN, you may have some side effects, mostly in the eye and due to the
injection procedure. The most common side effects are burning sensation, eye pain, redness, light sensitivity, vision loss, blurred vision, visual disturbances, high blood
pressure, and cataract. For a complete list of side effects, please ask your doctor or see
the prescribing information.
You should not receive MACUGEN if you have an infection in or around your eye or if you are hypersensitive (allergic) to pegaptanib sodium or any of the other ingredients.
A serious eye infection can sometimes develop after an injection into the eye. Signs of a
serious infection may include eye pain, light sensitivity, and/or vision changes. Check
with a retinal physician immediately if you experience any of these symptoms,so you can
be treated early if an infection occurs.
Eye injections like those with MACUGEN can increase eye pressure. This is something you would not notice; however, your retinal physician may do some extra tests after your
injection to make sure there are no complications.
In rare cases, allergic reactions have been known to occur. Tell your retinal physician about any known allergies.
Please follow your retinal physician's recommendations for your therapy. If you have any questions about MACUGEN, ask your retinal physician.
See Full Prescribing Information
You will need Adobe® Reader® to download this file. If you don't have Adobe Reader, you can download it for free.
Adobe and Adobe Reader are registered trademarks of Adobe Systems Incorporated.
To listen to the full prescribing information regarding MACUGEN, please click on the link entitled "Important Safety Information" on the menu bar located on the left of the screen.
























